Integrated Genomic Analysis using Nexus Copy Number and Nexus Expression
Integration of genomic data from different modalities (e.g. copy number variation, gene expression, miRNA expression, etc.) is a major area of interest with the growing ability to extract such information using high throughput methods such as microarrays. In this presentation we will highlight how BioDiscovery’s Nexus Copy Number and Nexus Expression software solutions can be used by research scientists to integrate knowledge gain from one modality with another to create a complete picture of the underlying biology. We will use data generated by The Cancer Genome Atlas (TCGA) project on a set of ovarian cancer samples. The data will include copy number and LOH analysis from SNP arrays as well as mRNA and miRNA data generated using microarray technology. We will show how to identify regions of significant copy number change that are predictive of survival and how the expression of the genes in these regions can also be predictive of survival. Time permitting, we will also look at the effect of miRNA expression changes on target gene expression.
Before you can View…
Search
Recent Publications
Feb. 2012 - LA Forsberg et. al.
Age-related somatic structural changes in the nuclear genome of human blood cells.
READ MOREFeb. 2012 - T Rausch et. al.
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations.
READ MOREJanuary 2012 - C Wu et. al.
Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.
READ MORERecent News
BioDiscovery’s Nexus Copy Number 6 Significantly Improves Analysis of Cancer Samples with New ASCAT Processing
EL SEGUNDO, CA, August 31, 2011 - BioDiscovery, Inc. a leader in integrated software solutions for genomics data analysis from high-throughput microarray and Next-Gen sequencing technologies announced today inclusion of the Allele Specific Copy number Ana... Read More
Upcoming Events
BioDiscovery’s Nexus Copy Number 6 Significantly Improves Analysis of Cancer Samples with New ASCAT Processing
EL SEGUNDO, CA, August 31, 2011 - BioDiscovery, Inc. a leader in integrated software solutions for g[...]
BioDiscovery Releases Nexus Copy Number Version 6.0 for DNA Copy Number Analysis and Visualization
BioDiscovery Releases Nexus Copy Number Version 6.0 for DNA Copy Number Analysis and Visualization [...]
Affymetrix selects BioDiscovery as OncoScan™ FFPE Express preferred software provider
Custom Nexus Copy Number™ solution and consulting streamlines difficult cancer sample analysis. E[...]




